Nanthealth, inc. (NH)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Jun'15
Revenue
Revenue

18,180

27,710

22,356

25,686

20,209

22,862

22,292

22,047

22,263

-

21,760

23,514

-

-

-

-

-

-

-

Software-as-a-service related

-

-

-

-

-

-

-

-

-

-

-

-

598

-138

2,065

4,149

674

4,493

3,942

Software and hardware related

-

-

-

-

-

-

-

-

-

-

-

-

14,797

13,328

14,000

15,181

13,701

4,143

3,412

Maintenance

-

-

-

-

-

-

-

-

-

-

-

-

2,019

-540

1,979

4,512

3,138

2,897

2,545

Total software-related revenue

-

-

-

-

-

-

-

-

-

-

-

-

17,414

13,190

16,065

19,330

14,375

8,636

7,354

Sequencing and molecular analysis

-

-

-

-

-

-

-

-

-

-

-

-

510

482

77

45

0

75

0

Home health care services

-

-

-

-

-

-

-

-

-

-

-

-

1,180

-4,331

2,541

7,603

1,938

2,797

1,853

Total net revenue

-

-

-

-

-

-

-

-

-

-

-

-

19,104

8,801

20,662

31,490

19,451

14,405

11,752

Cost of Revenue:
Total cost of revenue

7,196

-

-

-

10,261

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Software-as-a-service related

-

-

-

-

-

-

-

-

-

-

-

-

6,233

1,987

4,159

9,314

4,423

1,670

1,830

Software and hardware related

-

-

-

-

-

-

-

-

-

-

-

-

1,004

-386

528

435

239

74

91

Maintenance

-

-

-

-

-

-

-

-

-

-

-

-

161

-587

112

743

530

694

102

Amortization of developed technologies

-

-

-

-

-

-

-

-

-

-

-

-

1,743

-1,730

2,044

3,897

4,281

2,889

2,246

Total software-related cost of revenue

-

-

-

-

-

-

-

-

-

-

-

-

9,141

1,601

4,687

9,749

4,662

1,744

1,921

Sequencing and molecular analysis

-

-

-

-

-

-

-

-

-

-

-

-

1,593

1,058

570

359

0

39

0

Home health care services

-

-

-

-

-

-

-

-

-

-

-

-

784

-1,549

2,623

7,492

3,565

6,725

2,030

Cost of Revenue

-

-

8,372

9,816

-

-

11,226

10,582

11,068

-

11,472

9,652

11,518

-1,207

10,036

22,240

13,038

12,091

6,299

Gross Profit

10,984

17,737

13,984

15,870

9,948

11,469

11,066

11,465

11,195

13,418

10,288

13,862

7,586

10,008

10,626

9,250

6,413

2,314

5,453

Operating Expenses
Selling, general and administrative

12,427

15,406

15,136

15,177

15,324

14,637

17,001

18,388

20,737

20,795

17,521

19,225

17,435

8,603

22,034

47,248

27,373

18,147

17,847

Research and development

3,550

6,070

4,568

4,584

3,850

5,041

4,835

5,889

5,151

8,811

7,749

8,376

8,926

2,334

9,960

24,322

10,694

7,027

4,960

Amortization of acquisition-related assets

867

-

1,054

1,054

1,054

-

1,054

1,054

1,054

-

1,054

1,054

1,054

-

1,054

-

-

-

-

Impairment of intangible assets

-

-

0

3,977

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Amortization of acquisition-related assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,813

1,815

760

-11

Total operating expenses

16,844

22,531

20,758

24,792

20,228

20,733

22,890

25,331

26,942

30,660

26,324

28,655

27,415

10,472

33,048

73,383

39,882

25,934

22,796

Loss from operations

-5,860

-4,794

-6,774

-8,922

-10,280

-9,264

-11,824

-13,866

-15,747

-17,242

-16,036

-14,793

-19,829

-464

-22,422

-64,133

-33,469

-23,620

-17,343

Interest expense, net

-4,657

-4,601

-4,556

-4,473

-4,414

-4,355

-4,306

-4,262

-4,197

-4,119

-4,067

-4,013

-3,969

-1,758

-1,415

-1,758

-1,498

1

-303

Other income (expense), net

3,454

-586

-3,588

1,054

-2,505

-16,948

226

-1,334

180

492

60

13

235

3,228

104

-77

338

662

555

Income (Loss) from Equity Method Investments

-1,784

-1,916

-1,983

-2,208

-2,210

-18,897

-83,306

-2,945

-3,261

-3,981

-2,942

-38,885

-4,526

-33,101

-2,604

-2,375

-2,914

0

-145

Loss from continuing operations before income taxes

-8,847

-11,897

-16,901

-14,549

-19,409

-49,464

-99,210

-22,407

-23,025

-24,850

-22,985

-57,678

-28,089

-32,095

-26,337

-68,343

-37,543

-22,957

-17,236

Provision for income taxes

93

56

-527

133

226

-244

-1,778

-601

-1,050

-2,288

30

18

37

-5,243

55

-14,211

-4,398

1

0

Net loss from continuing operations

-8,940

-11,953

-16,374

-14,682

-19,635

-49,220

-97,432

-21,806

-21,975

-22,562

-23,015

-57,696

-28,126

-

-26,392

-

-

-

-

Income (loss) from discontinued operations, net of tax

32,005

204

-3

-31

-288

97

-32

-1,591

-193

928

-19,383

-12,368

-12,989

-

-10,482

-

-

-

-

Net Income (Loss) Attributable to Parent

23,065

-11,749

-16,377

-14,713

-19,923

-49,123

-97,464

-23,397

-22,168

-21,634

-42,398

-70,064

-41,115

-59,951

-36,874

-54,132

-33,145

-22,958

-17,236

Continuing operations - common stock (in usd per share)

-0.08

-0.11

-0.15

-0.13

-0.18

-0.45

-0.89

-0.20

-0.20

-

-0.20

-0.48

-0.23

-

-

-

-

-

-

Discontinued operations - common stock (in usd per share)

0.29

0.00

0.00

0.00

0.00

-0.01

0.00

-0.01

0.00

-

-0.17

-0.10

-0.11

-

-

-

-

-

-

Total net income (loss) per share - common stock (in usd per share)

0.21

-0.11

-0.15

-0.13

-0.18

-0.46

-0.89

-0.21

-0.20

-

-0.37

-0.58

-0.34

-

-

-

-

-

-0.21

Weighted average shares outstanding
Basic and diluted - common stock (shares)

110,619

-

110,619

110,209

109,904

-

109,471

109,120

108,579

-

115,924

121,756

121,618

-

-

-

-

-

82,406

Software and hardware related
Revenue

-

-

1,009

3,099

-

-

1,450

885

1,455

-

-

-

-

-

-

-

-

-

-

Cost of goods and services

-

-

624

794

-

-

737

789

885

-

-

-

-

-

-

-

-

-

-

Maintenance
Net revenue

-

-

2,743

2,535

-

2,478

2,522

2,388

2,446

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

0

760

484

311

70

241

234

234

215

-

-

-

-

-

-

-

-

-

-

Total software-related revenue
Revenue

18,121

27,558

22,080

23,925

17,802

20,545

19,909

19,493

20,067

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

6,844

9,494

7,910

7,991

7,011

7,884

8,067

8,057

8,875

-

-

-

-

-

-

-

-

-

-

Software-as-a-service related
Revenue

18,121

-

18,328

18,291

17,802

-

15,937

16,220

16,166

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

5,701

-

5,659

5,743

5,708

-

5,863

5,741

6,602

-

-

-

-

-

-

-

-

-

-

Amortization of developed technologies

-

-

1,143

1,143

-

-

1,233

1,293

1,173

-

-

-

-

-

-

-

-

-

-

Sequencing and molecular analysis
Revenue

59

152

276

491

814

623

742

924

840

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

352

479

462

1,177

2,427

2,612

2,323

1,689

1,431

-

-

-

-

-

-

-

-

-

-

Home Health Care Services [Member]
Revenue

0

0

0

1,270

1,593

1,694

1,641

1,630

1,356

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

0

0

0

648

823

897

836

836

762

-

-

-

-

-

-

-

-

-

-

Amortization of developed technologies
Total cost of revenue

1,143

-

-

-

1,233

-

-

-

-

-

-

-

-

-

-

-

-

-

-